NSE BSE
vivanza biosciences limited stock

Vivanza Biosciences Limited Share Price

- - (%)
Sector: -

530057

VIVANZA

img img img img
No Data Available

Vivanza Biosciences Limited : Share Price Update


As of the latest trading session, Vivanza Biosciences Limited share price is currently at 7.3, which is down by -0.23 from its previous closing. Today, the stock has fluctuated between 7.16 and 7.65. Over the past year, Vivanza Biosciences Limited has achieved a return of -50.65 %. In the last month alone, the return has been -14.81 %.

Vivanza Biosciences Limited Performance

Day Range

Low7.16 High7.65
7.19

52 Week Range

Low 5.70 High 15.20
7.19

Open Price

7.65

Prev. Close

7.53

Volume (Shares)

74564.00

Total traded value

5.36

Upper Circuit

7.54

Lower Circuit

6.84

Note: The current prices & values are delayed, Login to your account for live updates.

Vivanza Biosciences Limited Fundamentals


(Standalone)

Market Cap (Cr) 29.20
PE Ratio (TTM) 94.13
Book Value / Share 1.18
Beta 0.53
ROE 13.57%
EPS (TTM) 0.08
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.38

Vivanza Biosciences Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 2.30
Operating Expense 2.53
Net Profit -0.38
Net Profit Margin (%) -16.52
Earnings Per Share (EPS) -0.09
EBITDA -0.17
Effective Tax Rate (%) -40.74
Particulars DEC 2023 (Values in Cr)
Revenue 3.37
Operating Expense 3.20
Net Profit 0.18
Net Profit Margin (%) 5.34
Earnings Per Share (EPS) 0.05
EBITDA 0.28
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 3.87
Operating Expense 3.73
Net Profit 0.19
Net Profit Margin (%) 4.90
Earnings Per Share (EPS) 0.05
EBITDA 0.30
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 4.88
Operating Expense 4.56
Net Profit 0.33
Net Profit Margin (%) 6.76
Earnings Per Share (EPS) 0.08
EBITDA 0.44
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 6.02
Operating Expense 6.08
Net Profit -0.05
Net Profit Margin (%) -0.83
Earnings Per Share (EPS) -0.14
EBITDA 0.16
Effective Tax Rate (%) 200.00
Particulars MAR 2024 (Values in Cr)
Revenue 14.41
Operating Expense 14.04
Net Profit 0.32
Net Profit Margin (%) 2.22
Earnings Per Share (EPS) 0.08
EBITDA 0.85
Effective Tax Rate (%) 25.58
Particulars MAR 2023 (Values in Cr)
Revenue 14.21
Operating Expense 13.91
Net Profit 0.57
Net Profit Margin (%) 4.01
Earnings Per Share (EPS) 1.42
EBITDA 1.10
Effective Tax Rate (%) 17.39
Particulars MAR 2022 (Values in Cr)
Revenue 9.15
Operating Expense 9.52
Net Profit 0.46
Net Profit Margin (%) 5.02
Earnings Per Share (EPS) 1.16
EBITDA 0.88
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 9.22
Operating Expense 9.58
Net Profit 0.10
Net Profit Margin (%) 1.08
Earnings Per Share (EPS) 0.25
EBITDA 0.63
Effective Tax Rate (%) 33.33
Particulars MAR 2020 (Values in Cr)
Revenue 9.43
Operating Expense 10.17
Net Profit -0.20
Net Profit Margin (%) -2.12
Earnings Per Share (EPS) -0.51
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.02
ROE % 14.84
ROCE % 10.65
Total Debt to Total Equity 1.78
EBITDA Margin 6.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.73
ROE % 8.25
ROCE % 10.96
Total Debt to Total Equity 0.88
EBITDA Margin 7.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.90
ROE % 2.26
ROCE % 15.32
Total Debt to Total Equity 0.12
EBITDA Margin 6.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.29
EBITDA Margin 2.39
Particulars MAR 2019 (Values in Cr)
Book Value / Share 8.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin -0.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.10
ROE % 13.57
ROCE % 11.56
Total Debt to Total Equity 1.33
EBITDA Margin 7.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.57
ROE % 11.50
ROCE % 14.13
Total Debt to Total Equity 0.64
EBITDA Margin 9.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.41
ROE % 2.75
ROCE % 16.25
Total Debt to Total Equity 0.05
EBITDA Margin 6.83
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin 2.55
Particulars MAR 2019 (Values in Cr)
Book Value / Share 8.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.23
EBITDA Margin -1.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 22.47
Total Liabilities 22.47
Total Equity 4.09
Share Outstanding 40000000
Price to Book Ratio 17.09
Return on Assets (%) 2.66
Return on Capital (%) 4.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 15.56
Total Liabilities 15.56
Total Equity 3.49
Share Outstanding 4000000
Price to Book Ratio 19.71
Return on Assets (%) 2.13
Return on Capital (%) 3.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -3.09
Total Assets 8.44
Total Liabilities 8.44
Total Equity 3.15
Share Outstanding 4000000
Price to Book Ratio 15.53
Return on Assets (%) 0.89
Return on Capital (%) 2.14
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments -2.77
Total Assets 12.35
Total Liabilities 12.35
Total Equity 3.08
Share Outstanding 4000000
Price to Book Ratio 0.00
Return on Assets (%) -1.66
Return on Capital (%) -5.93
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments -2.99
Total Assets 11.10
Total Liabilities 11.10
Total Equity 3.28
Share Outstanding 4000000
Price to Book Ratio 0.00
Return on Assets (%) -3.97
Return on Capital (%) -9.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 20.44
Total Liabilities 20.44
Total Equity 4.39
Share Outstanding 40000000
Price to Book Ratio 17.09
Return on Assets (%) 2.78
Return on Capital (%) 5.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 14.20
Total Liabilities 14.20
Total Equity 3.82
Share Outstanding 4000000
Price to Book Ratio 19.71
Return on Assets (%) 3.26
Return on Capital (%) 5.62
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -3.11
Total Assets 7.93
Total Liabilities 7.93
Total Equity 3.36
Share Outstanding 4000000
Price to Book Ratio 15.53
Return on Assets (%) 1.25
Return on Capital (%) 2.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments -2.81
Total Assets 12.27
Total Liabilities 12.27
Total Equity 3.26
Share Outstanding 4000000
Price to Book Ratio 0.00
Return on Assets (%) -1.65
Return on Capital (%) -5.92
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments -3.02
Total Assets 10.83
Total Liabilities 10.83
Total Equity 3.46
Share Outstanding 4000000
Price to Book Ratio 0.00
Return on Assets (%) -4.14
Return on Capital (%) -10.27
Particulars MAR 2023 (Values in Cr)
Net Income 0.71
Cash from Operations -0.82
Cash from Investing 0.00
Cash from Financing 1.03
Net change in Cash 0.08
Free Cash Flow -0.82
Particulars MAR 2022 (Values in Cr)
Net Income 0.33
Cash from Operations 2.46
Cash from Investing 0.00
Cash from Financing -2.47
Net change in Cash -0.01
Free Cash Flow 2.46
Particulars MAR 2021 (Values in Cr)
Net Income 0.14
Cash from Operations -3.02
Cash from Investing -0.02
Cash from Financing 2.79
Net change in Cash -0.30
Free Cash Flow -3.00
Particulars MAR 2020 (Values in Cr)
Net Income -0.20
Cash from Operations 2.97
Cash from Investing 0.00
Cash from Financing -2.75
Net change in Cash 0.22
Free Cash Flow 2.97
Particulars MAR 2019 (Values in Cr)
Net Income -0.44
Cash from Operations 0.86
Cash from Investing 0.00
Cash from Financing -0.89
Net change in Cash -0.03
Free Cash Flow 0.86
Particulars MAR 2023 (Values in Cr)
Net Income 0.68
Cash from Operations 0.27
Cash from Investing 0.00
Cash from Financing -0.07
Net change in Cash 0.08
Free Cash Flow 0.27
Particulars MAR 2022 (Values in Cr)
Net Income 0.46
Cash from Operations -0.67
Cash from Investing 0.00
Cash from Financing 0.65
Net change in Cash -0.02
Free Cash Flow -0.67
Particulars MAR 2021 (Values in Cr)
Net Income 0.14
Cash from Operations -3.02
Cash from Investing -0.02
Cash from Financing 2.79
Net change in Cash -0.30
Free Cash Flow -3.00
Particulars MAR 2020 (Values in Cr)
Net Income -0.20
Cash from Operations 2.79
Cash from Investing 0.00
Cash from Financing -2.58
Net change in Cash 0.21
Free Cash Flow 2.79
Particulars MAR 2019 (Values in Cr)
Net Income -0.44
Cash from Operations 1.37
Cash from Investing 0.00
Cash from Financing -1.37
Net change in Cash 0.00
Free Cash Flow 1.37
Company Name Price P/E P/B Market Cap 52 Week Low/High
Vivanza Biosciences Limited 7.53 53.79 6.49 30.12 5.70 / 15.20
AEGIS LOGISTICS LIMITED 597.55 40.82 5.75 20974.01 280.00 / 707.20
AMBALAL SARABHAI ENTERPRISES L 44.66 117.53 2.69 342.24 20.90 / 70.00
KOTHARI INDUSTRIAL CORPORATION 5.04 0.00 0.58 9.63 1.80 / 5.04
MYSORE PETRO CHEMICALS LTD. 174.00 10.52 0.52 114.55 107.05 / 235.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
Vivanza Biosciences Limited 7.53 94.13 6.38 30.12 5.70 / 15.20
AEGIS LOGISTICS LIMITED 597.55 47.54 9.44 20974.01 280.00 / 707.20
AMBALAL SARABHAI ENTERPRISES L 44.66 0.00 9.40 342.24 20.90 / 70.00
COMPUTER POINT LTD. 4.89 489.00 0.43 14.67 2.25 / 6.57
NOVARTIS INDIA LTD. 1062.85 30.81 3.52 2624.26 599.95 / 1224.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 7.10
  • 26 Days 7.60
  • 10 Days 7.10
  • 50 Days 7.60
  • 12 Days 7.20
  • 100 Days 8.20
  • 20 Days 7.40
  • 200 Days 14.10
7.13
PIVOT
First Resistance 7.25
Second Resistance 7.32
Third Resistance 7.44
First Support 7.06
Second Support 6.94
Third Support 6.87
RSI 30.65
MACD -0.34
Commodity Channel Index (CCI) -61.40
ADX 15.62
Williams % R -57.58

Over 1 Month

down

-14.81

Over 3 Months

down

-12.10

Over 6 Months

down

-22.10

Over 1 Year

down

-50.65

Over 3 Years

down

3.63

Over 5 Years

down

33.74

Vivanza Biosciences Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Vivanza Biosciences Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
56.76
Promoter Holdings
43.23
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Parth Hemant Parikh Shareholding of Promoter and Promoter Group 1.719551E7 42.99
Ardent Ventures Llp Public Shareholding 9237000.0 23.09
Ashoka Metcast Ltd Public Shareholding 7749088.0 19.37
Hemant Amrish Parikh Shareholding of Promoter and Promoter Group 100211.0 0.25

Vivanza Biosciences Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2023-03-24 10.0 1.0 2023-03-24

Learn More About Stocks

About Vivanza Biosciences Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Vivanza Biosciences Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vivanza Biosciences Ltd?

Answer Field

The share price of Vivanza Biosciences Ltd for NSE is ₹ 0.00 and for BSE is ₹ 7.3.

What is the Market Cap of Vivanza Biosciences Ltd?

Answer Field

The market cap of Vivanza Biosciences Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 29.20 Cr. as of now.

What is the 52 Week High and Low of Vivanza Biosciences Ltd?

Answer Field

The 52 Week High and Low of Vivanza Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 15.20 and ₹ 5.70.

How to Buy Vivanza Biosciences Ltd share?

Answer Field

You can trade in Vivanza Biosciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vivanza Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been -45.63%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader